Primary information |
---|
PRRID | PRRID_0464 |
Ligand Name | diaminopimelic acid (C12-iEDAP) |
Source | Gram-negative and Gram-positive bacteria |
Sequence of ligand | N[C@@H](CCC[C@@H](NC(=O)CC[C@@H](N)C(O)=O)C(O)=O)C(O)=O |
Length | NA |
Type | Muropeptide |
Occurence | Natural |
Role of Ligand | It's binding to NOD1 induce NFκB activation, activation of MAP kinases and expression of chemokines CCL5 (RANTES) and CXCL1 (KC) and of nitric oxide |
Name of receptor | Nucleotide Binding Oligomerization Domain Containing 1 (Nod1) |
Type of receptor | NOD-like receptor (NLR) |
Source | C57BL/6 Mice |
Localization | liver and Hepatocytes |
Domain | NA |
Sequence of Receptor | Q8BHB0.fasta |
Swiss prot ID | Q8BHB0 |
Length Of Receptor | 953 |
Function | It helps in attracting leukocytes to the liver during infection and for hepatic NLRs to augment innate immune responses to pathogens. |
Assay used | Immunoblotting and EMSA |
PMID | 20615568 |
Year of Publication | 2010 |
Pubchem assay | Pubchem Assay |
Primary information |
---|
PRRID | PRRID_0464 |
Ligand Name | diaminopimelic acid (C12-iEDAP) |
Source | Gram-negative and Gram-positive bacteria |
Sequence of ligand | N[C@@H](CCC[C@@H](NC(=O)CC[C@@H](N)C(O)=O)C(O)=O)C(O)=O |
Length | NA |
Type | Muropeptide |
Occurence | Natural |
Role of Ligand | It's binding to NOD1 induce NFκB activation, activation of MAP kinases and expression of chemokines CCL5 (RANTES) and CXCL1 (KC) and of nitric oxide |
Name of receptor | Nucleotide Binding Oligomerization Domain Containing 1 (Nod1) |
Type of receptor | NOD-like receptor (NLR) |
Source | C57BL/6 Mice |
Localization | liver and Hepatocytes |
Domain | NA |
Sequence of Receptor | Q8BHB0.fasta |
Swiss prot ID | Q8BHB0 |
Length Of Receptor | 953 |
Function | It helps in attracting leukocytes to the liver during infection and for hepatic NLRs to augment innate immune responses to pathogens. |
Assay used | Immunoblotting and EMSA |
PMID | 20615568 |
Year of Publication | 2010 |
Pubchem assay | Pubchem Assay |